Quantum Mutual FundEquity Scheme - Small Cap Fund3 years
The Scheme seeks to generate capital appreciation by investing predominantly in Small Cap Stocks. There is no assurance that the investment objective of the scheme will be achieved.
Buying brief
Evidence on this desk, framed as a purchase checklist - not SEBI-registered advice.
As of 30 Oct 2026
Stance
Watch before adding
Recent evidence is mixed. Compare peers before increasing exposure.
In three lines
Fits if · Long-term category-relative performance remains stronger than the most recent rolling 1-year windows, which have deteriorated across multiple periods.
Prefer peers if · Prefer Bajaj Finserv Small Cap Fund if you want a same-category peer with stronger evidence.
Buy checklist
History depth
Watch
3.0 years - usable, still building a track record.
Engine status
Watch
Recent evidence is mixed. Compare peers before increasing exposure.
Expense ratio
Pass
0.83% TER (Direct). Lower cost compounds on long SIPs.
Drawdown vs peers
Pass
Peak-to-trough -18.2%. Ask whether you can hold through a similar fall.
Vs category
n/a
Category relative read still thin.
Manager tenure
Pass
Abhilasha Satale · 3.0 years on the scheme.
Exit load
n/a
No exit-load summary on file.
Tax / wrapper
Pass
Direct Growth, no ELSS lock flagged. Equity LTCG rules still apply after one year - not tax advice.
Portfolio concentration
Pass
Top 10 holdings ≈ 32.3% of the portfolio.
Same-category peers are preloaded into compare when available.
Behaviour and wrappers - the usual India MF failure modes - not a buy instruction.
Drawdown rehearsal
This scheme’s worst fall on file is about 18%. Before you SIP, ask whether you would keep contributing through a similar drop - pausing on fear is the usual India MF failure mode.
SIP discipline
Monitor is recent mixed evidence - keep the SIP unless the buying brief says prefer peers, then swap with intent.
NAV
Path not in current snapshots
n/a
Trailing CAGR and simulated monthly SIP XIRR from daily NAV. Category comparison uses the median of comparable share classes in the peer set.
Trailing CAGR
Point-to-point, calendar-day annualized
SIP XIRR
Equal monthly instalments to latest NAV
Peak to trough from a running NAV high, with the path and recovery episodes.
Drawdown
Path not in current snapshots
n/a
5 Sept 2024 – 9 Jun 2025
Trough 3 Mar 2025 · recovered in 98 days
-18.2%
17 Jul 2025 – 26 May 2026
Trough 23 Mar 2026 · recovered in 64 days
-15.0%
8 Sept 2026 – open
Trough 23 Oct 2026 · not recovered
-10.7%
7 Feb 2024 – 26 Apr 2024
Trough 13 Mar 2024 · recovered in 44 days
-7.7%
0–100 reads of named metrics. The mean is unweighted and only uses dimensions with data.
Returns
19
Vs category
7
Consistency
54
Risk-adjusted
38
Drawdown
55
Mean
35
Quantitative engine reasons behind the buying stance. An explanation can only restate what is already here.
Buying stance
Watch before adding
Recent evidence is mixed. Compare peers before increasing exposure.
Why this status
Supporting reads
No supporting reads in the current evidence set.
30 Sept 2026 · 59 holdings · top 10 are 32.3%.
Repo
Unspecified
6.9%
Supriya Lifescience Ltd
Healthcare
4.0%
Engineers India Ltd
Industrials
3.2%
Uniparts India Ltd
Industrials
2.8%
Karur Vysya Bank Ltd
Financial
2.7%
PERFORMANCE
Recent rolling excess versus the category median has deteriorated.
30 Oct 2026
PERFORMANCE
Recent rolling excess versus the category median has deteriorated.
29 Oct 2026
PERFORMANCE
Recent rolling excess versus the category median has deteriorated.
27 Oct 2026
PERFORMANCE
Recent rolling excess versus the category median has deteriorated.
26 Oct 2026
PERFORMANCE
Recent rolling excess versus the category median has deteriorated.
23 Oct 2026
PERFORMANCE
Recent rolling excess versus the category median has deteriorated.
22 Oct 2026
PERFORMANCE
Recent rolling excess versus the category median has deteriorated.
21 Oct 2026
PERFORMANCE
Recent rolling excess versus the category median has deteriorated.
19 Oct 2026
PERFORMANCE
Recent rolling excess versus the category median has deteriorated.
16 Oct 2026
PERFORMANCE
Recent rolling excess versus the category median has deteriorated.
24 Sept 2026
PERFORMANCE
Recent rolling excess versus the category median has deteriorated.
23 Sept 2026
PERFORMANCE
Recent rolling excess versus the category median has deteriorated.
21 Sept 2026
Same-category peers with enough history to inspect beside this fund - including tradeoffs.
Bajaj Finserv Mutual Fund
Caveat: Higher volatility · Higher TER
Bandhan Mutual Fund
Caveat: Higher volatility · Deeper drawdown
Bank of India Mutual Fund
Caveat: Higher volatility · Deeper drawdown
Edelweiss Mutual Fund
Caveat: Higher volatility · Deeper drawdown
HDFC Mutual Fund
Caveat: Higher volatility · Deeper drawdown
Quantum Mutual FundEquity Scheme - Small Cap Fund3 years
The Scheme seeks to generate capital appreciation by investing predominantly in Small Cap Stocks. There is no assurance that the investment objective of the scheme will be achieved.
Buying brief
Evidence on this desk, framed as a purchase checklist - not SEBI-registered advice.
As of 30 Oct 2026
Stance
Watch before adding
Recent evidence is mixed. Compare peers before increasing exposure.
In three lines
Fits if · Long-term category-relative performance remains stronger than the most recent rolling 1-year windows, which have deteriorated across multiple periods.
Prefer peers if · Prefer Bajaj Finserv Small Cap Fund if you want a same-category peer with stronger evidence.
Buy checklist
History depth
Watch
3.0 years - usable, still building a track record.
Engine status
Watch
Recent evidence is mixed. Compare peers before increasing exposure.
Expense ratio
Pass
0.83% TER (Direct). Lower cost compounds on long SIPs.
Drawdown vs peers
Pass
Peak-to-trough -18.2%. Ask whether you can hold through a similar fall.
Vs category
n/a
Category relative read still thin.
Manager tenure
Pass
Abhilasha Satale · 3.0 years on the scheme.
Exit load
n/a
No exit-load summary on file.
Tax / wrapper
Pass
Direct Growth, no ELSS lock flagged. Equity LTCG rules still apply after one year - not tax advice.
Portfolio concentration
Pass
Top 10 holdings ≈ 32.3% of the portfolio.
Same-category peers are preloaded into compare when available.
Behaviour and wrappers - the usual India MF failure modes - not a buy instruction.
Drawdown rehearsal
This scheme’s worst fall on file is about 18%. Before you SIP, ask whether you would keep contributing through a similar drop - pausing on fear is the usual India MF failure mode.
SIP discipline
Monitor is recent mixed evidence - keep the SIP unless the buying brief says prefer peers, then swap with intent.
NAV
30 Oct 2026 · -1.7% over 1Y
12.89
Trailing CAGR and simulated monthly SIP XIRR from daily NAV. Category comparison uses the median of comparable share classes in the peer set.
Trailing CAGR
Point-to-point, calendar-day annualized
SIP XIRR
Equal monthly instalments to latest NAV
Peak to trough from a running NAV high, with the path and recovery episodes.
Drawdown
30 Oct 2026
-10.5%
5 Sept 2024 – 9 Jun 2025
Trough 3 Mar 2025 · recovered in 98 days
-18.2%
17 Jul 2025 – 26 May 2026
Trough 23 Mar 2026 · recovered in 64 days
-15.0%
8 Sept 2026 – open
Trough 23 Oct 2026 · not recovered
-10.7%
7 Feb 2024 – 26 Apr 2024
Trough 13 Mar 2024 · recovered in 44 days
-7.7%
0–100 reads of named metrics. The mean is unweighted and only uses dimensions with data.
Returns
19
Vs category
7
Consistency
54
Risk-adjusted
38
Drawdown
55
Mean
35
Quantitative engine reasons behind the buying stance. An explanation can only restate what is already here.
Buying stance
Watch before adding
Recent evidence is mixed. Compare peers before increasing exposure.
Why this status
Supporting reads
No supporting reads in the current evidence set.
30 Sept 2026 · 59 holdings · top 10 are 32.3%.
Repo
Unspecified
6.9%
Supriya Lifescience Ltd
Healthcare
4.0%
Engineers India Ltd
Industrials
3.2%
Uniparts India Ltd
Industrials
2.8%
Karur Vysya Bank Ltd
Financial
2.7%
PERFORMANCE
Recent rolling excess versus the category median has deteriorated.
30 Oct 2026
PERFORMANCE
Recent rolling excess versus the category median has deteriorated.
29 Oct 2026
PERFORMANCE
Recent rolling excess versus the category median has deteriorated.
27 Oct 2026
PERFORMANCE
Recent rolling excess versus the category median has deteriorated.
26 Oct 2026
PERFORMANCE
Recent rolling excess versus the category median has deteriorated.
23 Oct 2026
PERFORMANCE
Recent rolling excess versus the category median has deteriorated.
22 Oct 2026
PERFORMANCE
Recent rolling excess versus the category median has deteriorated.
21 Oct 2026
PERFORMANCE
Recent rolling excess versus the category median has deteriorated.
19 Oct 2026
PERFORMANCE
Recent rolling excess versus the category median has deteriorated.
16 Oct 2026
PERFORMANCE
Recent rolling excess versus the category median has deteriorated.
24 Sept 2026
PERFORMANCE
Recent rolling excess versus the category median has deteriorated.
23 Sept 2026
PERFORMANCE
Recent rolling excess versus the category median has deteriorated.
21 Sept 2026